Should all patients be optimized to the same preoperative hemoglobin level to avoid transfusion in primary knee arthroplasty?

Vox Sanguinis

Volumn 107, Issue 2, 2014, Pages 148-152

  Basora, M ^a   Tio M ^a   Martin, N ^a   Lozano, L ^a   Salazar, F ^a   Sanchez Etayo G ^a   Raquel, B ^a   Pereira, A ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Arthroplasty; Erythrocyte transfusion; Hemoglobin; Knee replacement; Tranexamic acid

Indexed keywords

ANTIFIBRINOLYTIC AGENT; HEMOGLOBIN; TRANEXAMIC ACID;

ADULT; AGED; BLOOD; BLOOD TRANSFUSION; FEMALE; HUMAN; JOINT DISEASES; KNEE ARTHROPLASTY; MALE; METABOLISM; MIDDLE AGED; PRACTICE GUIDELINE; PREOPERATIVE CARE; RETROSPECTIVE STUDY; RISK; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION; FEMALE; HEMOGLOBINS; HUMANS; JOINT DISEASES; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK; TRANEXAMIC ACID;

EID: 84904409825     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12147     Document Type: Article

References (32)

1. Feagan BG, Wong CJ, Lau CY, et al.: Transfusion practice in elective orthopaedic surgery. Transfus Med 2001; 11:87-95
2. Biarnés A, Ciércoles E, Márquez E, et al.: Risk factors for transfusion in primary knee arthroplasty. Rev Esp Anestesiol Reanim 2006; 53:18-24
3. Glynn A, McCarthy T, McCarroll M, et al.: A prospective audit of blood usage post primary total knee arthroplasty. Acta Orthop Belg 2006; 72:24-28
4. Bong MR, Patel V, Chang E, et al.: Risks associated with blood transfusion after total knee arthroplasty. J Arthroplasty 2004; 19:281-287
5. Larocque BJ, Gilbert K, Brien WF: A point score system for predicting the likelihood of blood transfusion after hip or knee arthroplasty. Transfusion 1997; 37:463-467
6. Larocque BJ, Gilbert K, Brien WF: Prospective validation of a point score system for predicting blood transfusion following hip or knee replacement. Transfusion 1998; 38:932-937
7. Rashiq S, Shah M, Chow AK, et al.: Predicting allogeneic blood transfusion use in total joint arthroplasty. Anesth Analg 2004; 99:1239-1244
8. Grosflam JM, Wright EA, Cleary PD, et al.: Predictors of blood loss during total hip replacement surgery. Arthritis Care Res 1995; 8:167-173
9. Salido JA, Marín LA, Gómez LA, et al. Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am 2002; 84-A:216-220
10. Keating EM, Meding JB, Faris PM, et al.: Predictors of transfusion risk in elective knee surgery. Clin Orthop Relat Res 1998; 357:50-59
11. Guerin S, Collins C, Kapoor H, et al.: Blood transfusion requirement prediction in patients undergoing primary total hip and knee arthroplasty. Transfus Med 2007; 17:37-43
12. Goodnough LT, Maniatis A, Earnshaw P, et al.: Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011; 106:13-22
13. Kagoma YK, Crowther MA, Douketis J, et al.: Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 2009; 123:687-696
14. Alshryda S, Sarda P, Sukeik M, et al.: Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 2011; 93:1577-1585
15. Yang ZG, Chen WP, Wu LD: Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 2012; 94:1153-1159
16. Zhang H, Chen J, Chen F, et al.: The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 2012; 20:1742-1752
17. Alvarez JC, Santiveri FX, Ramos I, et al.: Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion 2008; 48:519-525
18. European Medicine Agency. The European Commission issued a decision for tranexamic acid, 10 October 2012. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Antifibrinolytic_medicines/WC500122923.pdf [Last accessed 7 January 2014]
19. Shander A, Van Aken H, Colomina MJ, et al.: Patient blood management in Europe. Br J Anaesth 2012; 109:55-68
20. Spahn DR: Anemia and patient blood management in hip and knee surgery. Anesthesiology 2010; 113:482-495
21. Basora M, Deulofeu R, Salazar F, et al.: Improved preoperative iron status assessment by soluble transferrin receptor in elderly patients undergoing knee and hip replacement. Clin Lab Haematol 2006; 28:370-375
22. Ganzoni AM: Intravenous iron-dextran: therapeutic and experimental possibilities. Schweiz Med Wochenschr 1970; 100:301-303
23. Lozano M, Basora M, Peidro L, et al.: Effectiveness and safety of tranexamic acid administration during total knee arthroplasty. Vox Sang 2008; 95:39-44
24. Long JS, Freese J: Regression Models for Categorical Dependent Variables Using STATA. Stata Press, College Station, TX, USA, 2001
25. CRASH-2 trial collaborators, Shakur H, Roberts I, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376:23-32
26. Poultsides LA, Gonzalez Della Valle A, et al. Meta-analysis of cause of death following total joint replacement using different thromboprophylaxis regimens. Bone Joint Surg Br 2012;94:113-121
27. Torres-Claramunt R, Ramirez M, López-Soques M, et al.: Predictors of blood transfusión in patients undergoing elective surgery for degenerative conditions of the spine. Arch Orthop Trauma Surg 2012; 132:1393-1398
28. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2011, Issue 3. Art. No.: CD001886. DOI:10.1002/14651858.CD001886.pub4
29. Bierbaum BE, Callaghan JJ, Galante JO, et al.: An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81:2-10
30. Rosencher N, Kerkkamp HE, Macheras G, et al.: Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43:459-469
31. Basora M, Colomina MJ, Moral V, et al.: Descriptive study of perioperative transfusion practices in Spanish hospitals. Transfus Altern Transfus Med 2007; 10:9-16
32. So-Osman C, Nelissen R, Te Slaa R, et al.: A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte-depleted red blood cells. Vox Sang 2010; 98:56-64